Circulating Extracellular Vesicles: An Effective Biomarker for Cancer Progression

被引:1
|
作者
Chatterjee, Madhura [1 ]
Gupta, Saurabh [2 ]
Nag, Sayoni [3 ]
Rehman, Ishita [4 ]
Parashar, Deepak [5 ]
Maitra, Arindam [1 ]
Das, Kaushik [1 ]
机构
[1] Natl Inst Biomed Genom, Biotechnol Res & Innovat Council, Kalyani 741251, India
[2] GLA Univ, Dept Biotechnol, Mathura 281406, India
[3] Brainware Univ, Dept Biotechnol, Barasat 700125, India
[4] Neotia Univ, Dept Biotechnol, Parganas 743368, India
[5] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, Milwaukee, WI 53226 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2024年 / 29卷 / 11期
关键词
biomarkers; cancer biomarkers; circulating extracellular vesicles; clinical trials; extracellular vesicles; therapeutics; POTENTIAL DIAGNOSTIC BIOMARKERS; EXOSOME-MEDIATED TRANSFER; INTERCELLULAR COMMUNICATION; CELLS PROMOTES; MESSENGER-RNA; PROGNOSTIC BIOMARKER; SERUM EXOSOMES; MICROVESICLES; EXPRESSION; MECHANISM;
D O I
10.31083/j.fbl2911375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular vesicles (EVs), the ubiquitous part of human biology, represent a small heterogenous, membrane-enclosed body that contains a diverse payload including genetic materials in the form of DNA, RNAs, small non-coding RNAs, etc. mostly mirroring their source of origin. Since, a vast majority of research has been conducted on how nucleic acids, proteins, lipids, and metabolites, associated with EVs can be effectively utilized to identify disease progression and therapeutic responses in cancer patients, EVs are increasingly being touted as valuable and reliable identifiers of cancer biomarkers in liquid biopsies. However, the lack of comprehensive clinical validation and effective standardization protocols severely limits its applications beyond the laboratories. The present review focuses on understanding the role of circulating EVs in different cancers and how they could potentially be treated as cancer biomarkers, typically due to the presence of bioactive molecules such as small non-coding RNAs, RNAs, DNA, proteins, etc., and their utilization for fine-tuning therapies. Here, we provide a brief general biology of EVs including their classification and subsequently discuss the source of circulatory EVs, the role of their associated payload as biomarkers, and how different cancers affect the level of circulatory EVs population.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Isolation of cfDNA and circulating extracellular vesicles allows for biomarker detection in a single aliquot of breast cancer patients' plasma
    Mugoni, Vera
    Nardella, Caterina
    Quaini, Orsetta
    Ciani, Yari
    Notarangelo, Michela
    Ferro, Antonella
    Caffo, Orazio
    D'Agostino, Vito
    Demichelis, Francesca
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 98 - 99
  • [32] Extracellular vesicles and biomarker discovery
    Falasca, Marco
    Manfredi, Marcello
    SEMINARS IN CANCER BIOLOGY, 2024, 107 : 103 - 105
  • [33] Extracellular vesicles as a promising biomarker resource in liquid biopsy for cancer
    Tamura, Takaaki
    Yoshioka, Yusuke
    Sakamoto, Shinichi
    Ichikawa, Tomohiko
    Ochiya, Takahiro
    EXTRACELLULAR VESICLES AND CIRCULATING NUCLEIC ACIDS, 2021, 2 (02): : 148 - 174
  • [34] Cancer liquid biopsy with mutated proteins in circulating extracellular vesicles
    Ueda, Koji
    CANCER SCIENCE, 2025, 116 : 1830 - 1830
  • [35] CIRCULATING EXTRACELLULAR VESICLES ARE A BIOMARKER FOR NONALCOHOLIC STEATOHEPATITIS RESOLUTION AND RESPONSE TO WEIGHT LOSS SURGERY
    Nakao, Yasuhiko
    Mauer, Amy S.
    Amrollahi, Pouya
    Parthasarathy, Gopanandan
    Sehrawat, Tejasav S.
    Vanderboom, Patrick
    Nair, K. Sreekumaran
    Nakao, Kazuhiko
    Allen, Alina M.
    Hu, Tony Y.
    Malhi, Harmeet
    HEPATOLOGY, 2020, 72 : 902A - 903A
  • [36] Circulating extracellular vesicles as a predictive biomarker for acute graft-versus-host disease
    Carneiro, Thiago Xavier
    Marrese, Daniella Gregolin
    Santos, Melina Goncalves dos
    Goncalves, Matheus Vescovi
    Novis, Yana Augusta Sarkis
    Rizzatti, Edgar Gil
    Rocha, Vanderson
    Sandes, Alex Freire
    Lacerda, Marcelo Pitombeira de
    Arrais-Rodrigues, Celso
    EXPERIMENTAL HEMATOLOGY, 2023, 117 : 15 - 23
  • [37] CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles
    Andriessen, Anneloes
    Bongiovanni, Laura
    Driedonks, Tom A. P.
    van Liere, Elsbeth
    Seijger, Anne
    Hegeman, Charlotte, V
    van Nimwegen, Sebastiaan A.
    Galac, Sara
    Westendorp, Bart
    Nolte-'t Hoen, Esther N. M.
    de Bruin, Alain
    VETERINARY AND COMPARATIVE ONCOLOGY, 2022, 20 (02) : 381 - 392
  • [38] Mitochondrial DNA mutation detection in tumors and circulating extracellular vesicles of triple negative breast cancer patients for biomarker development
    Vikramdeo, Kunwar
    Anand, Shashi
    Sudan, Sarabjeet
    Pramanik, Paramahansa
    Singh, Seema
    Godwin, Andrew
    Singh, Ajay
    Dasgupta, Santanu
    CANCER RESEARCH, 2024, 84 (09)
  • [39] Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection
    Moon, Pyong-Gon
    Lee, Jeong-Eun
    Cho, Young-Eun
    Lee, Soo Jung
    Jung, Jin Hyang
    Chae, Yee Soo
    Bae, Han-Ik
    Kim, Young-Bum
    Kim, In-San
    Park, Ho Yong
    Baek, Moon-Chang
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1757 - 1766
  • [40] Identification of developmental endothelial locus-1 on circulating extracellular vesicles as a novel biomarker for early breast cancer detection
    Moon, Pyong-Gon P.
    Lee, Jeong-Eun
    Cho, Young-Eun
    Lee, Soo Jung
    Jung, Jin Hyang
    Chae, Yee Soo
    Bae, Han-Ik
    Kim, Young-Bum
    Kim, In-San
    Park, Hoyong
    Baek, Moon-Chang
    CANCER RESEARCH, 2016, 76